Mar 10, 2020
SK life science Receives Schedule V Designation from DEA for XCOPRI® (cenobamate tablets)
Jan 09, 2020
Mercaptor Discoveries Announces Preclinical Program in Epilepsy
Jul 18, 2019
Mesa Science Associates to Present on Canine Epilepsy at The Kansas City Animal Health Corridor Annual Investors Meeting
Oct 10, 2018
Evogen's Cognizance Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent for Its Diagnostic Biomarkers for Epilepsy
Jun 27, 2018
Upsher-Smith Features Access Pathways® Program Platinum Pass At Annual Scientific Meeting Of The American Headache Society
Apr 18, 2018
Upsher-Smith Launches New Access Pathways® Platinum Pass At 2018 American Academy Of Neurology Annual Meeting
Dec 02, 2017
Evogen Study at 2017 AES Annual Meeting Identifies New Proteomic Biomarkers for Diagnosis of Epileptic Seizures
Nov 29, 2017
Upsher-Smith Showcases Access Pathways(TM) Program At 71st Annual Meeting Of The American Epilepsy Society
Nov 16, 2017
Global Epilepsy Epidemiology and Patient Flow Analysis - 2017
Nov 14, 2017
Upsher-Smith To Attend American Headache Society (AHS) Annual Scottsdale Headache Symposium
Oct 19, 2017
Biscayne Neurotherapeutics Reports Successful Phase 1b Clinical Trial Results For Its Novel Antiepileptic Agent
Oct 18, 2017
Upsher-Smith Announces Attendance At Upcoming American Academy Of Neurology 2017 Fall Conference
Sep 27, 2017
Evogen Receives U.S. Patent Covering Its Novel Epilepsy Blood Test
Aug 21, 2017
Upsher-Smith Launches Newly Designed Website For Qudexy® XR (topiramate) Extended-Release Capsules